Published in
Springer, International Journal of Clinical Oncology, 8(27), p. 1300-1308, 2022
DOI: 10.1007/s10147-022-02179-9
Links
Tools
Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study)
Journal article published in 2022 by
Shun Ishiyama,
Takeshi Yamada 
,
Masato Nakamura,
Masanobu Enomoto,
Kiichi Sugimoto,
Hajime Yokomizo,
Chihiro Kosugi,
Ryo Ohta,
Kei Ishimaru,
Hiromichi Sonoda,
Keiichiro Ishibashi,
Hidekazu Kuramochi,
Yoichiro Yoshida,
Daisuke Ichikawa,
Keiji Hirata
and other authors.
,
Masato Nakamura,
Masanobu Enomoto,
Kiichi Sugimoto,
Hajime Yokomizo,
Chihiro Kosugi,
Ryo Ohta,
Kei Ishimaru,
Hiromichi Sonoda,
Keiichiro Ishibashi,
Hidekazu Kuramochi,
Yoichiro Yoshida,
Daisuke Ichikawa,
Keiji Hirata
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 